Table 2.
Diagnosis and management of chronic endometritis (CE)
| Diagnosis of CE by indication for endometrial sampling | n (%) | p-value* |
|---|---|---|
| All indications (N = 653) | 186 (28.5) | < 0.001 |
| RPL (n = 258) | 72 (27.9) | |
| IF (n = 183) | 24 (13.1) | |
| FTL (n = 70) | 47 (66.2) | |
| Other (n = 142) | 43 (30.5) | |
| Antibiotic treatment after diagnosis of CE (N = 171) | n (%) | |
| Doxycycline (200 mg/day) | 130 (76.0) | |
| Ofloxacin (800 mg/day) and metronidazole (1000 mg/day) | 5 (2.9) | |
| Augmentin (2 g/day) | 5 (2.9) | |
| Ciprofloxacin (500 mg/day) and metronidazole (500 mg/day) | 7 (4.1) | |
| Other (see Appendix Table 4) | 24 (14.0) | |
| Test of cure (TOC) performed (N = 171) | n (%) | |
| No | 21 (12.3) | |
| Yes | 150 (87.7) | |
| Persistent CE on TOC # 1 (N = 150) | n (%) | |
| No | 102 (68.5) | |
| Yes | 47 (31.5) | |
| Antibiotic treatment after diagnosis of persistent CE (N = 45) | n (%) | |
| Doxycycline (200 mg/day) | 7 (15.6) | |
| Ofloxacin (800 mg/day) and metronidazole (1000 mg/day) | 2 (4.4) | |
| Augmentin (2 g/day) | 4 (8.9) | |
| Ciprofloxacin (500 mg/day) and metronidazole (500 mg/day) | 22 (48.9) | |
| Other (see Appendix Table 5) | 10 (22.2) | |
| TOC #2 performed (N = 45) | n (%) | |
| No | 4 (8.9) | |
| Yes | 41 (91.1) | |
| Refractory CE on TOC #2 (N = 41) | n (%) | |
| No | 27 (65.9) | |
| Yes | 14 (34.1) |
*p-value comparing differences in rates of chronic endometritis by indication for ES